AIDS Research and Treatment / 2022 / Article / Tab 1 / Research Article
A Retrospective Study of Incidence and Predictors on Mother-to-Child Transmission of HIV among HIV-Exposed Infants in West Guji Zone, Southern Ethiopia Table 1 Clinical characteristics of mothers of HIV-exposed infants in general hospitals of West Guji Zone, Oromia, Ethiopia, 2020 (n = 422).
Variables Frequency % (n = 422) HIV test results of infants Positive (%) Negative (%) The WHO clinical stage at baseline Mild stage (I, II) 350 83 10 (2.0) 304 (72.0) Advanced stage (III, IV) 72 17 10 (2.0) 98 (23.0) The WHO clinical stage at last visit of pregnancy Mild stage (I, II) 400 95 3 (1.0) 398 (94.0) Advanced stage (III, IV) 22 5 7 (2.0) 14 (3.0) CD4 count at baseline ≥500 72 17 0 (0.0) 48 (11.0) 351–499 89 21 0 (0.0) 112 (27.0) 200–350 175 41 3 (1.0) 176 (42.0) <200 86 20 10 (2.0) 73 (17.0) CD4 count at pregnancy (n = 422) ≥500 166 39 1 (0.0) 186 (44.0) 351–499 126 30 0 (0.0) 122 (29.0) 200–350 86 20 3 (1.0) 83 (20.0) <200 44 10 8 (2.0) 19 (5.0) Functional status at baseline Working 298 71 7 (2.0) 248 (59.0) Ambulatory 113 27 7 (2.0) 109 (26.0) Bedridden 11 3 7 (2.0) 44 (10.0) Time of knowing HIV status Before pregnancy 294 70 9 (2.0) 277 (66.0) During pregnancy or after 128 30 5 (1.0) 131 (31.0) Enrolment to PMTCT Yes 396 94 14 (3.0) 312 (74.0) No 26 6 14 (3.0) 82 (19.0) Time of enrolment to PMTCT Before pregnancy on HAART 272 64 5 (1.0) 188 (45.0) During pregnancy 118 28 5 (1.0) 142 (34.0) During labor and delivery or after 32 8 5 (1.0) 77 (18.0) ART adherence at last visit of pregnancy Good 268 64 7 (2.0) 294 (70.0) Fair 86 20 3 (1.0) 68 (16.0) Poor 68 16 3 (1.0) 47 (11.0) OIs at base line No 182 43 2 (0.0) 211 (50.0) Yes 240 57 12 (3.0) 197 (47.0) Disclosure status Yes 316 75 7 (2.0) 322 (76.0) No 106 25 7 (2.0) 86 (20.0) Last viral load during pregnancy Undetectable 324 77 8 (2.0) 329 (78.0) Detectable 98 23 6 (1.0) 79 (19.0) Nutritional status during pregnancy Not malnourished 335 79 7 (2.0) 322 (76.0) Malnourished 87 21 6 (1.0) 89 (21.0)